BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21345278)

  • 1. Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.
    Singer M; Jones AM
    Crit Care; 2011 Jan; 15(1):203. PubMed ID: 21345278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
    Caliezi C; Wuillemin WA; Zeerleder S; Redondo M; Eisele B; Hack CE
    Pharmacol Rev; 2000 Mar; 52(1):91-112. PubMed ID: 10699156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and efficacy of purified human C1-esterase inhibitor in the treatment of patients with sepsis].
    Lazareva NB; Igonin AA
    Antibiot Khimioter; 2009; 54(1-2):42-6. PubMed ID: 19499717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus.
    Schartz ND; Sommer AL; Colin SA; Mendez LB; Brewster AL
    Physiol Behav; 2019 Dec; 212():112705. PubMed ID: 31628931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.
    Igonin AA; Protsenko DN; Galstyan GM; Vlasenko AV; Khachatryan NN; Nekhaev IV; Shlyapnikov SA; Lazareva NB; Herscu P
    Crit Care Med; 2012 Mar; 40(3):770-7. PubMed ID: 22080632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
    Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
    J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
    Li HH; Mycroft S; Christiansen S; Wood DN; Feuersenger H; Pawaskar D; Jacobs I
    Allergy Asthma Proc; 2018 Sep; 39(5):365-370. PubMed ID: 30107868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.
    Crowther M; Bauer KA; Kaplan AP
    Allergy Asthma Proc; 2014; 35(6):444-53. PubMed ID: 25584911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation inhibitor substitution during sepsis.
    Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
    Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage.
    Dalle Lucca JJ; Li Y; Simovic M; Pusateri AE; Falabella M; Dubick MA; Tsokos GC
    Shock; 2012 Jul; 38(1):82-91. PubMed ID: 22683724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-inhibitor: more than a serine protease inhibitor.
    Zeerleder S
    Semin Thromb Hemost; 2011 Jun; 37(4):362-74. PubMed ID: 21805442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of inhibitor kappaB kinase/ nuclear factor kappaB signaling during critical illness: a double-edged sword.
    Groesdonk HV; Senftleben U
    Crit Care Med; 2004 May; 32(5):1239; author reply 1239-40. PubMed ID: 15190989
    [No Abstract]   [Full Text] [Related]  

  • 16. C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice.
    Zwijnenburg PJ; van der Poll T; Florquin S; Polfliet MM; van den Berg TK; Dijkstra CD; Roord JJ; Hack CE; van Furth AM
    J Infect Dis; 2007 Jul; 196(1):115-23. PubMed ID: 17538891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke.
    Chen X; Arumugam TV; Cheng YL; Lee JH; Chigurupati S; Mattson MP; Basta M
    Neuromolecular Med; 2018 Mar; 20(1):63-72. PubMed ID: 29299869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation.
    Berger M; Lefaucheur C; Jordan SC
    Transplantation; 2019 Sep; 103(9):1763-1775. PubMed ID: 30946220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study.
    Melamed IR; Miranda H; Heffron M; Harper JR
    Front Immunol; 2021; 12():632744. PubMed ID: 33737935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.